Fletikumab: Clinical Trials

3 trials of Fletikumab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 withdrawn. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Terminated 2, Withdrawn 1

Follow Fletikumab: new trials by email Literature Review of Fletikumab trials Research Report on Fletikumab

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Trial Investigating the Mechanism of Action of NNC0109-0012 (Anti-IL-20 mAb) Through Synovial Biopsies in Subjects With Rheumatoid Arthritis and an Inadequate Response to Methotrexate
NNC0109-0012, Adalimumab, placebo - Inflammation, Rheumatoid Arthritis
Phase 2WithdrawnNovo Nordisk A/S2014-09-012014-08-15
A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Methotrexate
NNC0109-0012, placebo - Inflammation, Rheumatoid Arthritis
Phase 2TerminatedNovo Nordisk A/S2982012-10-302018-09-05
A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics
NNC0109-0012, placebo - Inflammation, Rheumatoid Arthritis
Phase 2TerminatedNovo Nordisk A/S2392012-08-012018-09-05

Conditions studied

Arthritis, Rheumatoid (3)  ·  Inflammation (3)

Sponsors

Novo Nordisk A/S (3)

Countries

Argentina (2)  ·  Belgium (2)  ·  Brazil (2)  ·  Czechia (2)  ·  France (2)  ·  Germany (2)  ·  Hungary (2)  ·  Italy (2)  ·  Mexico (2)  ·  Poland (2)  ·  Spain (2)  ·  United States (2)  ·  Russia (1)  ·  Ukraine (1)  ·  United Kingdom (1)